The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tooman Craig A since 2006.
The trader's CIK number is 1201050.
At the time of the last reporting, Tooman Craig A was the Exec VP Finance, CFO of Aratana Therapeutics, Inc.. (stock ticker symbol PETX).
Also see all insider trading activities at Aratana Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2018 | PETX | 0 | $0 | 30,000 | $158,040 | 0 | $0 |
2017 | PETX | 0 | $0 | 0 | $0 | 2,000 | $6,280 |
2016 | PETX | 0 | $0 | 32,806 | $287,026 | 0 | $0 |
2015 | PETX | 0 | $0 | 6,870 | $53,424 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2010 | ENZN | 0 | $0 | 273,100 | $2,775,894 | 313,540 | $2,191,972 |
2009 | ENZN | 0 | $0 | 16,236 | $101,527 | 24,240 | $0 |
2008 | ENZN | 0 | $0 | 0 | $0 | 7,500 | $0 |
2007 | ENZN | 1,000 | $8,189 | 0 | $0 | 0 | $0 |
2006 | ENZN | 1,000 | $6,868 | 0 | $0 | 0 | $0 |
1. Aratana Therapeutics, Inc. (PETX)
2. Enzon Pharmaceuticals, Inc. (ENZN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2018-01-11 | PETX | Sale | 30,000 | 5.27 | 158,040 |
2017-12-21 | PETX | Option Ex | 2,000 | 3.14 | 6,280 |
2016-09-09 | PETX | Sale | 30,000 | 9.25 | 277,590 |
2016-02-01 | PETX | Sale | 2,806 | 3.36 | 9,436 |
2015-11-09 | PETX | Sale | 3,620 | 7.52 | 27,236 |
2015-10-02 | PETX | Sale | 3,250 | 8.06 | 26,188 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2010-06-18 | ENZN | Option Ex | 140,800 | 8.59 | 1,209,472 |
2010-06-18 | ENZN | Sale | 123,100 | 11.25 | 1,385,244 |
2010-05-12 | ENZN | Option Ex | 6,000 | .00 | 0 |
2010-04-03 | ENZN | Option Ex | 16,740 | .00 | 0 |
2010-02-24 | ENZN | Sale | 150,000 | 9.27 | 1,390,650 |
2010-02-24 | ENZN | Option Ex | 150,000 | 6.55 | 982,500 |
2009-11-23 | ENZN | Option Ex | 3,000 | .00 | 0 |
2009-05-12 | ENZN | Option Ex | 4,500 | .00 | 0 |
2009-04-03 | ENZN | Option Ex | 16,740 | .00 | 0 |
2009-04-03 | ENZN | Sale | 5,930 | 6.12 | 36,291 |
2009-01-17 | ENZN | Sale | 10,306 | 6.33 | 65,236 |
2008-11-23 | ENZN | Option Ex | 3,000 | .00 | 0 |
2008-05-12 | ENZN | Option Ex | 4,500 | .00 | 0 |
2007-05-11 | ENZN | Buy | 1,000 | 8.19 | 8,189 |
2006-03-07 | ENZN | Buy | 1,000 | 6.87 | 6,868 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tooman Craig A (Exec VP Finance, CFO of Aratana Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.